Definitive Analysis

Financial Statements

Fundamentals

Valuations

Miscellaneous

Analysis Mode

Full Access

See Pricing Start Trial
Multiples Valuation: Jacobson Pharma Corporation Limited

Jacobson Pharma Corporation Limited (2633.HK)

Industry: Drug Manufacturers - Specialty & Generic Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $5.69 — $13.69
Selected (Average) $9.01
Upside to Live 604.09%
Full Range Fair Value
Range (Low - High) $9.14 — $14.72
Selected (Average) $11.51
Upside to Live 798.98%
Live Price $1.28

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
003220.KS 172 Daewon Pharmaceuti 409 34.81 44.23 4.22 3.60 - 22.01
600488.SS 173 Tianjin Tianyao Ph 408 270.71 410.51 37.66 48.11 42.55 28.58
243070.KQ 174 Huons Co., Ltd. 408 9.70 10.06 3.43 2.98 11.49 9.97
4551.T 175 Torii Pharmaceutic 408 63,223,171.90 56,090,829.95 44,902,065.65 37,233,931.38 59,042,495.16 44,883,980.01
DEVA.IS 176 Deva Holding A.S. 406 41.07 45.62 3.86 2.69 30.57 12.82
249420.KS 177 Ildong Pharmaceuti 397 - - 6.06 2.42 209.99 32.16
4538.T 178 Fuso Pharmaceutica 395 6.94 5.75 7.04 5.47 18.08 10.14
2633.HK 179 Jacobson Pharma Co 391 4.34 3.88 2.62 2.27 3.57 3.37
002688.SZ 180 Jinhe Biotechnolog 389 40.28 41.38 78.42 99.30 99.02 44.19
4015.SR 181 Jamjoom Pharmaceut 388 24.66 24.66 21.33 21.33 25.11 23.82
600211.SS 182 Tibet Rhodiola Pha 386 15.34 12.81 16.28 14.66 25.84 11.23
688131.SS 183 Shanghai Haoyuan C 385 59.41 48.16 45.84 45.84 36.98 47.28
300601.SZ 184 Shenzhen Kangtai B 383 - - 3,638.71 9,531.83 665.06 -
600513.SS 185 Jiangsu Lianhuan P 368 - - 178.44 240.23 136.11 103.66
002793.SZ 186 Luoxin Pharmaceuti 353 - - - - 80.89 -
068760.KQ 187 Celltrion Pharm, I 351 64.37 13.46 24.60 5.00 38.23 9.76

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple34.8124.6618.8110.0737.6022.01
Full Range Median Multiple40.2841.3822.9718.0040.3923.82
Industry Multiple5,747,612.655,099,226.053,207,580.822,660,282.494,217,422.503,452,641.20
Market Implied Multiple4.714.212.822.443.843.63
Company (2633.HK) Multiple4.343.882.622.273.573.37
(*) Net Income / EBITDA / Revenue69781281489499
Winsorized Enterprise ValueN/AN/A2,4041,4863,5282,188
Full Range Median Enterprise ValueN/AN/A2,9362,6583,7892,367
(-) Net Debt343434343434
Winsorized Equity Value2,4141,9112,3711,4523,4942,154
Full Range Median Equity Value2,7943,2082,9022,6243,7552,333
(/) Shares Outstanding255255255255255255
Winsorized Fair Value$9.46$7.49$9.29$5.69$13.69$8.44
Full Range Median Fair Value$10.95$12.57$11.37$10.28$14.72$9.14
Current Price$1.28$1.28$1.28$1.28$1.28$1.28
Upside / Downside639.29%485.29%625.85%344.75%969.88%559.46%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$6.62$5.24$6.50$3.98$9.59$5.91
Buy / Don't BuyBUYBUYBUYBUYBUYBUY